J. Roh, Hyun Mi Kim, Jun Nyun Kim, Sinyoung Kim, H. Kim
{"title":"Practical Considerations in Convalescent Plasma Therapy for Coronavirus Disease 2019","authors":"J. Roh, Hyun Mi Kim, Jun Nyun Kim, Sinyoung Kim, H. Kim","doi":"10.17945/kjbt.2020.31.1.67","DOIUrl":null,"url":null,"abstract":"Convalescent plasma therapy has been used to achieve passive immunization against diverse infectious agents by administering pathogen-specific antibodies Coronavirus disease 19 (COVID-19), which originated in Wuhan, China, has recently become a major concern all over the world There are no specific treatment recommendations for COVID-19 because of the lack of knowledge and evidence about this virus Convalescent plasma therapy can be used as an empirical and investigational treatment for COVID-19, and so we briefly describe the main issues related to convalescent plasma therapy from the perspective of transfusion medicine","PeriodicalId":231122,"journal":{"name":"The Korean Journal of Blood Transfusion","volume":"22 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2020-04-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"4","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"The Korean Journal of Blood Transfusion","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.17945/kjbt.2020.31.1.67","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 4
Abstract
Convalescent plasma therapy has been used to achieve passive immunization against diverse infectious agents by administering pathogen-specific antibodies Coronavirus disease 19 (COVID-19), which originated in Wuhan, China, has recently become a major concern all over the world There are no specific treatment recommendations for COVID-19 because of the lack of knowledge and evidence about this virus Convalescent plasma therapy can be used as an empirical and investigational treatment for COVID-19, and so we briefly describe the main issues related to convalescent plasma therapy from the perspective of transfusion medicine